|
Time*
|
Event
|
|
7:30 a.m. - 4:00 p.m.
|
Registration
|
|
7:30 a.m. - 8:30 a.m.
|
Continental Breakfast
|
|
8:30 a.m. - 11:30 a.m.
|
Innovation Corridor Session I
|
|
9:00 a.m. - 10:15 a.m.
|
Tracks Session I
|
|
Drug Delivery, Device, and Diagnostics
|
The Evolving Role of Diagnostics in Bioscience Technology and Health Care
|
|
Growth Strategies for Bioscience Companies
|
Virtues and Vices of Being Virtual
|
|
Regulatory
|
Biosimilars - Challenges and Opportunities
|
|
9:00 a.m. - 12:00 p.m.
|
Company Presentations Session I
|
|
9:00 a.m. - 12:00 p.m.
|
Partnering Session I
|
|
10:15 a.m. - 10:30 a.m.
|
Refreshment Break
|
|
10:30 a.m. - 11:45 a.m.
|
Tracks Session II
|
|
Drug Delivery, Device, and Diagnostics
|
New Trends in Drug Delivery of Biotechnology-Derived Therapeutics
|
|
Growth Strategies for Bioscience Companies
|
Creative Partnering: How to Thrive in the "New Normal"
|
|
Regulatory
|
The FDA Amendments Act of 2007 - What You Need to Know About the Ongoing Implementation
|
|
12:00 p.m. - 1:30 p.m.
|
Plenary Lunch
Federal Policy Update - What's Really Happening in D.C.
|
|
1:45 p.m. - 9:30 p.m.
|
Exhibit Hall
|
|
1:45 p.m. - 3:00 p.m.
|
Tracks Session III
|
|
Drug Delivery, Device, and Diagnostics
|
Advancements for the Diagnosis and Treatment of Neurological Disorders
|
|
Growth Strategies for Bioscience Companies
|
Developing Value for Your Exit Strategy
|
|
Regulatory
|
FDA and Industry Interactions in the Face of a Developing Pandemic
|
|
1:45 p.m. - 5:00 p.m.
|
Company Presentations Session II
|
|
1:45 p.m. - 4:45 p.m.
|
Partnering Session II
|
|
3:00 p.m. - 3:15 p.m.
|
Refreshment Break
|
|
3:15 p.m. - 4:45 p.m.
|
Plenary Session
An Overview of the Industry: Past, Present, and Future
|
|
4:45 p.m. - 6:30 p.m.
|
Networking Reception in Exhibit Hall
|
|
6:30 p.m. - 8:30 p.m.
|
Dinner & Keynote Address
David Holveck
President & CEO
Endo Pharmaceuticals
|
|
8:30 p.m. - 9:30 p.m.
|
Networking Dessert Reception in Exhibit Hall
|
